Bullish On Monte Rosa Therapeutics' 'Undruggable' Targets With QuEEN

Monte Rosa Therapeutics (NASDAQ: GLUE ) is a biotechnology company working on oncology, autoimmune, and inflammatory diseases. But what makes GLUE special is that it uses its proprietary Quantitative and Engineered Elimination of Neosubstrates [QuEEN] platform to selectively produce molecular glue degraders. On top of that, this approachMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. deg ...